清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

ERCC1-associated platinum resistance and PARP inhibition in lung cancers.

作者
Huaidong Cheng,Zijie Zhang,Charles A. Powell,Balázs Halmos
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:29 (15_suppl): e17533-e17533
标识
DOI:10.1200/jco.2011.29.15_suppl.e17533
摘要

e17533 Background: Platinum-based regimens are standard of care in advanced lung cancer despite low response rates. They damage DNA by forming platinum-DNA adducts. Tumor expression of ERCC1, a key enzyme in nucleotide excision repair, may predict the response to platinum agents with increased expression associated with resistance. We examined if combined impairment of two DNA repair pathways, PARP inhibition and low ERCC1 expression, would increase sensitivity to platinum agents in lung cancers. Methods: Cell viability and cell cycle effects were measured using MTS, clonogenic and BrdU proliferation assays. ERCC1 expression and phosphorylation of P53 and γH2A were determined by Western blots. Knockdown was performed using siRNA pools targeting ERCC1. All data were expressed as means ± SD from at least triplicates. Statistical analysis was performed by one- or two-way ANOVA. Results: A549, H157 lung cancer cells have high ERCC1 expression, whereas HCC827, PC9 have low expression. When different dose-combinations of cisplatin and olaparib (PARP inhibitor) were tested, olaparib selectively augmented cisplatin-induced growth inhibition in ERCC1-low but not in ERCC1-high cells. As a single agent, olaparib conferred selective cytotoxicity against ERCC1-low cells with no effects in ERCC1-high cells. Knockdown of ERCC1 in ERCC1-high A549 significantly increased sensitivities to olaparib and cisplatin. Treatment with cisplatin or olaparib led to an increase in the G2/M population in ERCC1-low cells with an even stronger effect seen with the combination. Cisplatin and olaparib activated DNA damage pathways as evidenced by increased phospho-γH2A levels. Olaparib and cisplatin alone or in combination increased phospho-P53 in ERCC-low HCC827 cells in a dose-dependent fashion. Conclusions: PARP inhibition selectively augments cisplatin sensitivity in ERCC1-low but not high lung cancer cells. Cisplatin sensitivity is enhanced by ERCC1 knockdown in ERCC1-high cells. PARP inhibition alone or in combination with cisplatin leads to G2/M cell cycle arrest, likely by activation of the pathway involving γH2A and P53. Our study may identify novel synergistic approaches based on synthetic lethality for lung cancer based on tumor ERCC1 expression.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
机智的如曼完成签到,获得积分10
6秒前
Xzx1995完成签到 ,获得积分10
8秒前
FashionBoy的应助被科研通管家采纳,获得10
11秒前
fairytaler的应助被科研通管家采纳,获得10
11秒前
现代的初之完成签到,获得积分10
17秒前
大模型的应助被蜗牛好好飞采纳,获得10
18秒前
ChatGPT完成签到,获得积分10
20秒前
慕青的应助被蜗牛好好飞采纳,获得10
24秒前
夏同学完成签到 ,获得积分10
25秒前
今后的应助被蜗牛好好飞采纳,获得10
30秒前
wwrjj完成签到,获得积分0
31秒前
搜集达人的应助被cc采纳,获得10
32秒前
大模型的应助被蜗牛好好飞采纳,获得10
35秒前
41秒前
41秒前
御坂10576号完成签到,获得积分10
41秒前
43秒前
义气的雅琴完成签到,获得积分10
44秒前
cc发布了新的文献求助10
46秒前
NexusExplorer的应助被蜗牛好好飞采纳,获得10
47秒前
Harlotte完成签到 ,获得积分0
48秒前
蒋不惜完成签到,获得积分10
54秒前
changfox完成签到,获得积分10
54秒前
hyk完成签到 ,获得积分10
54秒前
milalala完成签到 ,获得积分10
1分钟前
浚稚完成签到 ,获得积分10
1分钟前
1分钟前
冷傲的夜白完成签到,获得积分10
1分钟前
岳晓燕完成签到 ,获得积分10
1分钟前
1分钟前
清脆代真发布了新的文献求助50
1分钟前
1分钟前
谭访冬完成签到,获得积分10
1分钟前
MUAN完成签到 ,获得积分10
1分钟前
1分钟前
细腻海瑶完成签到,获得积分10
1分钟前
铁瓜李完成签到 ,获得积分10
1分钟前
1分钟前
红烧肉耶完成签到 ,获得积分10
2分钟前
小小菜完成签到 ,获得积分10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173230
求助须知:如何正确求助?哪些是违规求助? 9565593
关于积分的说明 21780525
捐赠科研通 7767429
什么是DOI,文献DOI怎么找? 3431542
关于科研通互助平台的介绍 2555764
邀请新用户注册赠送积分活动 2476697